Highlights•Psoriasis pathogenesis involved cytokines, microbial peptides, genetic
disposition.•Psoriasis is autoimmune disorder that affects approximately 125 million …

Psoriasis is a chronic immune-mediated inflammatory disorder. Phosphodiesterase-4 (PDE-
4) is an enzyme that mediates inflammatory responses and plays a role in psoriasis …

Psoriasis has historically been considered a nonpruritic dermatosis, in contrast with atopic
dermatitis. Thus, itch has often been underappreciated and overlooked in psoriasis …

The introduction of biologic therapies has led to dramatic improvements in the management
of moderate-to-severe psoriasis. Even though the efficacy and safety of the newer biologic …

The current state, tools, and applications of personalized medicine with special emphasis on
inflammatory skin diseases like psoriasis and atopic dermatitis are discussed. Inflammatory …

Psoriasis and atopic dermatitis represent two of the most common skin conditions seen by
both primary care and specialist dermatology. The prevalence of psoriasis in North America …

Psoriasis is a chronic immune-mediated disorder that commonly affects adults and children.
In recent years, pediatric psoriasis has increased in prevalence and the disease is often …

Psoriasis is a common chronic immune-mediated disease with many comorbidities and
impacts on quality of life. Among the treatments for psoriasis, phosphodiesterase-4 (PDE4) …

Psoriasis is a common inflammatory skin disorder, which is mediated by the immune system
and affects 1–4% of the world's population. Psoriasis is caused by a complex interaction …

Psoriasis is an incurable cutaneous illness characterized by the presence of well-delimited
reddish plaques and silvery-white dry scales. So far, there is a limited understanding of its …